Cited by 36Parasitic infections in humans and animalsHelminth infection and controlParasitic Diseases Research and Treatment

The DOI matches its Crossref record.

Treatment of hydatid disease in childhood with mebendazole

Gocmen, A, Toppare, MF, Kiper, N·1993·European Respiratory Journal

Abstract

The general characteristics of 56 childhood cases of cystic hydatid disease were analysed and the results of mebendazole therapy versus surgery were verified. Pulmonary radiograms and ultrasonography were used in the diagnosis. The cysts were localized primarily to the lungs. Twenty seven patients were surgically-treated, with eight having recurrence after a mean period of 3.6 yrs. Thirty patients received regular mebendazole treatment, in a dose of 50 mg.kg-1 with a mean duration of treatment of 11.7 months. Twenty one patients were cured and discontinued the therapy. Nine still use the drug, seven of whom have had dramatic improvement, while the other two have minimal radiographic changes but subjective improvement in general condition. The lung cysts vanished leaving minimal scars, whilst the liver cysts turned into inactive forms. The surgically-treated and drug-treated groups were similar in age, duration and severity of the disease. The recurrence rate of drug-treated children (1 out of 20) was lower than that of the surgically-treated children (8 out of 27); however, this was not statistically significant.

Overview

Integrity signals

Registry

Crossref · 10.1183/09031936.93.06020253

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In children with cystic echinococcosis, mebendazole (50 mg/kg daily for 9-18 months) was appropriate to use due to lack of side effects, high therapeutic effects, and low risk of recurrence.

    “in children, mebendazole (50 mg/kg daily for 9–18 months) was appropriate to use due to the lack of side effects, high therapeutic effects, and low risk of recurrence [186]”
  • In children patients with hydatid disease, even long-term mebendazole treatment (50 mg/kg daily for 9-18 months) was safe without significant side effects.

    “However, in children patients with hydatid disease, even long-term mebendazole treatment (50 mg/kg daily for 9–18 months) was safe without significant side effects [186].”

Citations

Cited by

Sorted by citations

Metadata

Authors
Gocmen, A., Toppare, M., & Kiper, N.
Venue
European Respiratory Journal
Published
1993-02-01
Volume
6
Issue
2
Pages
253-257
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W1926776606
Cited by
36
References
0
Citations by year
2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2015: 1 · 2013: 1 · 2012: 3
FWCI
0.54
Type
journal article
Language
en
Open access
closed
Locations
  • European Respiratory Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasitic infections in humans and animals
  • Life Sciences › Immunology and Microbiology › Parasitology › Helminth infection and control
  • Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
Keywords
echinococcosis, mebendazole, pediatric patients, antiparasitic chemotherapy, surgical treatment, recurrence, pulmonary hydatid cyst, hepatic hydatid cyst
MeSH terms
Adolescent, Child, Child, Preschool, Echinococcosis, Hepatic, Echinococcosis, Pulmonary, Follow-Up Studies, Humans, Mebendazole, Recurrence, Time Factors, Turkey

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review